A Precision-Based Approach for Bioactive Skin Allograft Application in Nonhealing Wounds Using Bacterial Fluorescence Imaging
This peer-reviewed case series addresses the clinical challenge of managing chronic, nonhealing wounds using advanced modalities – specifically, bioactive skin allografts (BSAs). BSAs are cellular and/or tissue-based products (CTPs) designed to promote tissue repair by supporting angioenesis, cellular proliferation, and immune modulation.
A key innovation discussed is the use of bacterial fluorescence imaging (FL-imaging), a noninvasive, point-of-care technology that detects clinically significant bioburden in wounds. The paper evaluates how FL-imaging can guide the application and monitoring of BSAs, aiming to improve outcomes and standardize care.
